Vaginal Estrogen Therapy and Yeast Infections
Vaginal estrogen therapy does not increase the risk of yeast infections (vulvovaginal candidiasis) and is considered safe for treating vaginal atrophy in postmenopausal women. 1
Relationship Between Estrogen and Yeast Infections
- Vaginal estrogen therapy has not been shown to increase the risk of urinary tract infections or yeast infections 1
- The American Urological Association, Canadian Urological Association, and Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction guidelines specifically state that vaginal estrogen therapy has minimal systemic risks due to low absorption 1
- Vaginal estrogen therapy is recommended for peri- and post-menopausal women with recurrent urinary tract infections to reduce future UTI risk 1
Biological Mechanisms
- While laboratory studies show that estrogen can promote Candida albicans colonization in experimental settings, this does not translate to clinical evidence of increased yeast infections with vaginal estrogen therapy 2, 3
- Research indicates that estrogen may affect how Candida interacts with the immune system, but clinical guidelines do not identify vaginal estrogen as a risk factor for yeast infections 4
- Estrogen actually helps restore normal vaginal flora with lactobacilli dominance, which can help prevent pathogenic bacterial colonization 1
Clinical Considerations
- Vulvovaginal candidiasis (VVC) is caused by Candida albicans or occasionally other Candida species and affects approximately 75% of women at least once in their lifetime 1
- Common symptoms of yeast infections include pruritus (itching), vaginal discharge, soreness, burning, dyspareunia, and external dysuria 1
- Diagnosis is made through clinical symptoms plus either microscopic identification of yeast/pseudohyphae or positive culture 1
- Yeast infections are associated with a normal vaginal pH (≤4.5), which is actually promoted by healthy estrogen levels 1
Treatment Options for Yeast Infections
- If a yeast infection does occur (regardless of cause), treatment options include:
Special Considerations
- For postmenopausal women using vaginal estrogen who develop a yeast infection, the same treatment approach as for younger women should be used 5
- Oral antifungal medications may be more acceptable for older women due to ease of administration 5
- Women with recurrent vulvovaginal candidiasis who have had hysterectomies may be more prone to harbor resistant fungi species, requiring more aggressive treatment 6
Practical Recommendations
- When prescribing vaginal estrogen therapy, reassure patients that it does not increase risk of yeast infections 1
- For women with vaginal atrophy symptoms, a stepwise approach is recommended:
- Start with lubricants and vaginal moisturizers
- If symptoms persist, low-dose vaginal estrogen can be safely used 1
- Vaginal estrogen preparations come in various forms including creams, tablets, and rings, all of which are effective for treating vaginal atrophy 1